Nu-Med Plus (NUMD) Depreciation & Amortization (CF) (2012 - 2022)

Nu-Med Plus (NUMD) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $35.0 in Q3 2022.

• For the quarter ending Q3 2022, Depreciation & Amortization (CF) fell 98.68% year-over-year to $35.0; the trailing twelve-month figure through Jun 2023 stood at $35.0 (down 99.54% YoY), and the FY2022 full-year result was $2267.0, down 75.79% from the prior year.
• Depreciation & Amortization (CF) retreated to $35.0 in Q3 2022, from $217.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $3803.0 in Q2 2018 to a low of $35.0 in Q3 2022.
• A 5-year average of $2712.4 and a median of $3048.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) surged 100.62% in 2018 and plunged 98.68% in 2022, its largest moves.
• Tracing NUMD's Depreciation & Amortization (CF) over 5 years: stood at $3774.0 in 2018, then fell by 19.55% to $3036.0 in 2019, then retreated by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021, then sank by 98.68% to $35.0 in 2022.
• Business Quant data shows NUMD's Depreciation & Amortization (CF) at $35.0 in Q3 2022, $217.0 in Q2 2022, and $2015.0 in Q1 2022.